Details:

Alternative Title:
Emerg Infect Dis
Publisher's site:
http://dx.doi.org/10.3201/eid2710.210620
Personal Author:
Puing, Alfredo G. ; Epstein, David J. ; Banaei, Niaz ; Subramanian, Aruna K. ; Liu, Anne Y.
Puing, Alfredo G. ; Epstein, David J. ; Banaei, Niaz ; Subramanian, Aruna K. ; Liu, Anne Y. Less -
Description:
Prophylactic trimethoprim/sulfamethoxazole (TMP/SMX) prevents Pneumocystis jirovecii pneumonia and nocardiosis in immunocompromised patients but sometimes is avoided because of purported allergies or side effects. Of 25 immunocompromised patients receiving alternative prophylaxis in whom nocardiosis developed, 16 subsequently tolerated TMP/SMX treatment. Clinicians should consider TMP/SMX allergy evaluation and rechallenging to assess patient tolerance.
Subject:
[+]
Humans Immunocompromised Host Nocardia Infections Pneumocystis Pneumocystis Carinii Pneumonia, Pneumocystis Retrospective Studies
Source:
Emerg Infect Dis. 27(10):2734-2736
Pubmed ID:
34545802
Pubmed Central ID:
PMC8462344
Document Type:
Journal Article
Collection(s):
Emerging Infectious Diseases
Main Document Checksum:
[+]
urn:sha256:f17b2809bfbb16a08767dde6241ce7b8818c3de0df4616a1f081a231c32b3e34
Download URL:
https://stacks.cdc.gov/view/cdc/110432/cdc_110432_DS1.pdf
File Type:

Supporting Files

• 	21-0620-F.gif	gif
  	21-0620-F.jpg	jpeg
  	21-0620-Techapp-s1.pdf	pdf
  	21-0620.nxml	xml

More +